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Holliday junctions (HJs), the DNA intermediates of
homologous recombination, need to be faithfully
processed in order to preserve genome integrity. In
human cells, the BLM helicase complex promotes
nonnucleolytic dissolution of double HJs. In vitro,
HJs may be nucleolytically processed by MUS81-
EME1, GEN1, and SLX4-SLX1. Here, we exploit
human SLX4-null cells to examine the requirements
for HJ resolution in vivo. Lack of BLM and SLX4 or
GEN1 and SLX4 is synthetically lethal in the absence
of exogenous DNA damage, and lethality is a conse-
quence of dysfunctional mitosis proceeding in the
presence of unprocessed HJs. Thus, GEN1 activity
cannot be substituted for the SLX4-associated
nucleases, and one of the HJ resolvase activities,
either of those associated with SLX4 or with GEN1,
is required for cell viability, even in the presence of
BLM. In vivo HJ resolution depends on both SLX4-
associated MUS81-EME1 and SLX1, suggesting
that they are acting in concert in the context of SLX4.
INTRODUCTION
Homologous recombination (HR) is a high-fidelity pathway for
the repair of double-strand breaks, interstrand crosslinks
(ICLs), and lesions arising during normal DNA replication (Li
and Heyer, 2008). Deficiency in HR results in a greatly increased
susceptibility to multiple cancers including those of the breast,
ovary, pancreas, and blood. The key step in the completion of
HR is processing of Holliday junctions (Holliday, 1964; Szostak
et al., 1983). All organisms possess a specific set of DNA pro-
cessing activities that can act on these HR intermediates.
Distinct genetic interactions between the genes coding for these
activities have been seen in different organisms and lack of or
inappropriate repair of HJs results in diverse mutant phenotypes
(Schwartz and Heyer, 2011). In mitotically dividing human cells,
at least four enzymatic activities are implicated in the processingCof HJs. BLM-TOP3a-RMI1-RMI2 complex is well established as
a Holliday junction dissolvase, able to branch migrate double
HJs toward one another and decatenate the DNA strands
without the use of structure specific endonucleases (Cejka
et al., 2010; Wu and Hickson, 2003). Alternatively, the nucleases
MUS81-EME1 (Chen et al., 2001; Constantinou et al., 2002; Tay-
lor and McGowan, 2008), GEN1 (Ip et al., 2008), and SLX1
(Andersen et al., 2009; Fekairi et al., 2009; Mun˜oz et al., 2009;
Svendsen et al., 2009) have been shown to have nucleolytic
activity on synthetic single HJs in vitro, and there is evidence
that they play a role in resolving HJs in vivo in human cells,
although their respective contributions to in vivo HJ resolution
are still undefined (Wechsler et al., 2011). Interestingly, both hu-
manMUS81 and SLX1 interact with SLX4, a scaffold protein that
is implicated in enhancing the activity of these two nucleases as
well as a third nuclease, XPF-ERCC1, which also binds to SLX4
(Andersen et al., 2009; Fekairi et al., 2009; Mun˜oz et al., 2009;
Svendsen et al., 2009).
We and others have reported mutations in SLX4 in patients
with Fanconi anemia (Kim et al., 2011; Stoepker et al., 2011), a
recessive disorder of bone marrow failure and cancer predispo-
sition that arises due to an inability to repair DNA ICLs (reviewed
in Kottemann and Smogorzewska, 2013). Using complementa-
tion of the SLX4-null Fanconi anemia patient cell line with a
number of SLX4 mutants deficient in binding to their nuclease
partners, we have established that the in vivo activity of the
XPF-ERCC1, MUS81-EME1, and SLX1 nucleases during DNA
repair relies strictly on their association with SLX4 and that the
nucleases are important for DNA repair of distinct DNA lesions
(Kim et al., 2013). XPF-SLX4 interaction is necessary for resis-
tance to ICL agents, and this nuclease acts in the incision step
of ICL repair (Kuraoka et al., 2000). MUS81-SLX4 interaction is
necessary for resistance to Topoisomerase I (TOP1) inhibitor
Camptothecin, as well as to PARP inhibitor (KU0058948 or Ola-
parib), and it is most likely involved in processing of stalled repli-
cation forks prior to the HR step (Ray Chaudhuri et al., 2012).
Finally, lack of SLX1-SLX4 interaction results in intermediate
sensitivity to ICL agents, CPT, and PARP inhibitor, suggesting
that SLX1-SLX4, although important, might be redundant with
other activities in the HR pathway. The SLX4 complementation
system we developed gives us a unique opportunity to assessell Reports 5, 207–215, October 17, 2013 ª2013 The Authors 207
Figure 1. Depletion of BLM or GEN1 in the
Absence of SLX4 Is Synthetically Lethal in
Human Cells
(A) Schematic of SLX4 illustrating select domains
and interacting nucleases, along with the
N-terminally HA-tagged SLX4 cDNAs used in all
experiments. Although the interaction of SLX1 and
SLX4 has been shown to be direct, SLX4-XPF-
ERCC1 and SLX4-MUS81-EME1 might not be
direct.
(B) Western analysis of immunoprecipitated HA-
tagged SLX4 and coimmunoprecipitated XPF or
MUS81 from cell lines used in the experiments that
follow. The lower band (*) indicates degradation
products.
(C–G) Survival of SLX4-null cells complemented
with indicated cDNAs and treated with siRNA
against luciferase (siCONTROL), siBLM, and
siGEN1. SLX4-null cells complemented with
empty vector (C), WT SLX4 cDNA (D), SLX4DMLR
lacking interaction with XPF (E), SLX4DSAP lack-
ing interaction with MUS81 (F), and SLX4DSBD
that lacks interaction with SLX1 (G). Three sepa-
rate siRNAs or a pool of three siRNAs were used
for these studies as indicated. Left panels show
cell morphology and the decreased cell number as
observed using a phase contrast microscope.
Right panels show cell survival as measured with
Cell Titer-Glo. Survival data show average of at
least six replicates for each siRNA, and the error
bars indicate SDs between replicates. Efficiency
of BLM and GEN1 depletion is shown in Figure S1.
See also Figure S1.the respective contributions of each of the SLX4-associated
nucleases to in vivo HJ resolution and to study their genetic inter-
actions with the other two HJ processing factors, GEN1 and
BLM, during unperturbed cell growth.
RESULTS
BLM or GEN1 were depleted in the SLX4-null human cell
line (RA3331/E6E7/hTERT) (Kim et al., 2011) complemented208 Cell Reports 5, 207–215, October 17, 2013 ª2013 The Authorswith an empty vector, wild-type
(WT) SLX4, SLX4 lacking interaction with
XPF (SLX4DMLR), SLX4 lacking inter-
action with MUS81 (SLX4DSAP), or
SLX4 lacking interaction with SLX1
(SLX4DSBD) (Kim et al., 2013; Figures
1A and 1B and S1). We observed
that the depletion of either BLM or
GEN1 induced synthetic lethality in the
absence of SLX4 and that the expression
of WT SLX4 suppressed the lethality
(Figures 1C and 1D). Moreover, both
MUS81 and SLX1, but not XPF asso-
ciation with SLX4 were necessary for
the suppression of synthetic lethality
caused by BLM or GEN1 depletion
(Figures 1E–1G).To identify themode of cell death in cells deficient for SLX4 and
BLM,or SLX4andGEN1,weemployed time-lapsemicroscopyof
GFP-H2B expressing SLX4-null and complemented cells
depleted of BLM or GEN1. Analysis of mitotic duration showed
that the length of mitosis was significantly prolonged in SLX4-
null cells depleted of either BLM or GEN1 (Figure 2A) and that
the defect was suppressed by expression of WT SLX4. We
observed that synthetic lethality in human cells deficient for
these proteins predominantly occurs as a consequence of
Figure 2. Mitotic Duration Is Greatly
Increased and the Majority of Mitoses Are
Abnormal in SLX4-Deficient Cells Depleted
of GEN1 or BLM
(A) Duration of mitosis (in minutes) assessed by
live-cell imaging of GFP-H2B-positive SLX4-null
cells complemented with vector or WT SLX4 and
also transfected with the indicated siRNAs. Each
value plotted represents a single cell undergoing
mitosis. Cells were scored from five independent
movies for each experimental condition. p values
were determined by one-way ANOVA.
(B) Outcome of mitoses in the experiment
described in (A). Cells entering mitosis and segre-
gating to yield two daughter cells were scored as
‘‘normal.’’ Cells that failed to segregate or did so
with lagging chromosomes or multiple daughters
were scored as ‘‘aberrant.’’ Cells that died during
mitosisor thosewithdaughter cells that diedduring
mitotic exit were scored as ‘‘death duringmitosis.’’
Values plotted represent the mean percentages of
scores from five independent movies for each
experimental condition. Error bars represent the
SD between the five replicates. See also Table S1.
(C–G) Nuclear morphology of SLX4-null cells
depleted of GEN1 or BLM. SLX4-null and com-
plemented cells transfected with indicated
siRNAs were stained with DAPI 96 hr after second
siRNA transfection. Nuclear morphology was
scored according to the example panel shown in
(C). Cells with irregular nuclei (D), with cata-
strophic nuclei (E), with micronuclei (F), and with
nuclear bridges (G) were counted. Note that cells
that die during mitosis were not counted because
they were not attached to a coverslip. Values
plotted represent the mean percentage from three
experimental replicates. Error bars represent the
SD of the replicate means.
See also Figure S2.dysfunctionalmitosis. Eighty-ninepercent ofmitoses inSLX4and
BLM doubly deficient cells and sixty-eight percent of mitoses in
SLX4- and GEN1-deficient cells were aberrant (failed to segre-
gate, had lagging chromosomes, or gave rise to more than two
daughters) or resulted in cell death (Figure 2B). Cleavage of
caspase 3 was increased in SLX4-null cells depleted of GEN1
or BLM, suggesting that some of the cells were dying by
apoptosis (Figure S2A). Once more, expression of WT-SLX4
rescued mitotic dysfunction and caspase activation in the
absence of GEN1 or BLM (Figures 2B and S2A). The prominent
feature of aberrant mitoses in both SLX4-GEN1- and SLX4-Cell Reports 5, 207–215,BLM-deficient backgrounds was mitotic
failure resulting in binucleated and multi-
nucleated cells (Table S1). We next as-
sessed the nuclear morphology in doubly
deficient cells by quantifying a number of
distinct nuclear abnormalities (Figure 2C).
Depletion of BLM or GEN1 in SLX4-null
cells led to an increase in the number of
cells with irregular nuclei and catastrophic
nuclei, and the defect was suppressed byWT or SLX4DMLR and partially suppressed by SLX4DSAP or
SLX4DSBD (Figures 2D and 2E). An increase in micronuclei (Fig-
ure2F)wasspecifically associatedwithGEN1depletion,whereas
nuclear bridges were increased in SLX4-null cells with both
GEN1 and BLM depletion (Figure 2G). The nuclear abnormalities
present in SLX4-null cells depleted of either GEN1 or BLM sug-
gested increased levels of genome instability, which was
confirmed by the increased staining of phosphorylated H2AX
(gH2AX) in SLX4-null cells depleted of GEN1 or BLM (Figures
S2B and S2C). The majority of micronuclei were gH2AX positive,
suggesting that they were derived from broken chromosomes.October 17, 2013 ª2013 The Authors 209
Figure 3. Depletion of BLMor GEN1 in the Absence of SLX4 Results in Distinct Chromosomal Phenotypes that Are Dependent onMUS81 and
SLX1
(A) Metaphase spreads from SLX4-null cells depleted of BLM or GEN1 showing presence of segmented chromosomes (siBLM) or paired acentric fragments
(siGEN1). Upper panels display whole metaphases. The boxed area is shown below at higher magnification. Paired acentric fragments (arrowhead) appear to
originate from telomere-proximal fragments that affect both sister chromatids (black arrow). Chromatid breaks are also seen (red arrows). See Figure S4 for
staining for telomeric DNA.
(B) Examples of scoring of sectors and paired acentric fragments used for quantification.
(C) Quantification of segmented chromosomes in SLX4-null and complemented cells depleted of BLM. Chromosomes with three or more segments were scored
in the indicated cell lines. There had to be at least two paired fragments, on the p and/or q arm, extending from the centric fragment, separated by gaps or breaks,
for a total of at least three segments. SLX4-null cells depleted of GEN1 showed no segmented chromosomes.
(legend continued on next page)
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In order to directly evaluate the type and level of genomic
instability, we assessed chromosomal morphology on meta-
phase spreads in SLX4-null cells depleted of BLM or GEN1.
Depletion of BLM from SLX4-null cells led to the appearance
of a striking phenotype of chromosomal segmentation (Figures
3A and 3B). This phenotype was previously observed when
different combinations of nucleases capable of processing HJs
were depleted from cells deficient for BLM protein (Wechsler
et al., 2011). The authors attributed the chromosome segmenta-
tion phenotype to lack of proper condensation at the sites of
chromatid entanglements that could not be properly processed
in the absence of HJ dissolution or resolution (Wechsler et al.,
2011). Cells expressing SLX4DSBD lacking the SLX1 interaction
or SLX4DSAP lacking MUS81 interaction also showed very high
levels of segmentation indicating that the SLX1 and MUS81
activities associated with SLX4 are essential for the suppression
of segmentation (Figure 3C).
Depletion of GEN1 fromSLX4-null cells does not result in chro-
mosomal segmentation (Figure 3A). However, metaphases from
SLX4- and GEN1-deficient cells showed the presence of paired
acentric telomere-proximal DNA fragments (Figures 3A and 3D,
black arrows) that often become physically separated from the
originating chromosome (Figure 3A, black arrowhead). These
fragments are positive for telomeric DNA (Figure S3A), indicating
that they arise from the tips of chromosomes. Similar to the
segmentation phenotype, the fragmentation is present on both
chromatids and appears to be symmetrical. Once again,
complementation of the SLX4-null cells with SLX4 that lacks
the MUS81 or SLX1 association were not able to fully suppress
the formation of these paired acentric fragments although
some suppression was evident.
We hypothesized that the segmentation and formation of the
acentric fragments was due to persistence of unresolved HJs
in cells deficient in SLX4andBLMorGEN1. To test that assertion,
we expressed one of the bacterial HJ resolvases, RusA (Doe
et al., 2000; Saintigny et al., 2002 and Figure 4A), in SLX4-defi-
cient cells and assessed segmentation and formation of acentric
fragments after depletion of BLM or GEN1 (Figures 4B and 4C).
RusA cleaves Holliday junctions in a symmetrical manner to yield
nicked duplex products (Chan et al., 1997; reviewed in Sharples
et al., 1999). Exogenous expression of bacterial RusA has been
used to pinpoint Holliday junction resolution defects in yeast
and human cells (Boddy et al., 2001; Doe et al., 2000; Saintigny
et al., 2002). Expression of wild-type RusA in SLX4-null cells
depleted of BLM or GEN1 was able to suppress both segmenta-
tion and acentric fragment formation respectively. In contrast, a
RusA D70N mutant deficient for in vitro HJ resolvase activity
was able to suppress neither the segmentation nor the acentric
fragment formation. This suggests that the observed chromo-
somal abnormalities are the outcome of inefficient HJ resolution
in cells that are deficient for SLX4 and BLM or SLX4 and GEN1.
To test directly the contribution of SLX4-associated nucleases
andGEN1 to HJ resolution activity, we have assessed the forma-(D) The acentric fragments (distinct pairs only) were quantified inSLX4-null and co
experiment shown in this figure, and the analysis was blinded. Means and SDs are
values are indicated for the statistically significant comparisons of interest.
See also Figure S3.
Ction of sister chromatid exchanges (SCEs), which arise from
crossover events and are therefore markers for nucleolytic
processing of HJs (Chaganti et al., 1974; Latt et al., 1975). As
expected, mitomycin-C (MMC)-induced SCEs were low in
SLX4-null cells and were increased when the cells are comple-
mented with WT SLX4 or SLX4 that is unable to interact with
XPF (Figure 5A). However, MMC-induced SCEs remained low
in cells that lacked SLX4-associated MUS81 or SLX1. Depletion
of GEN1 in SLX4-null cells, but not in the SLX4-complemented
cells, led to further suppression of SCEs (Figure 5B). A different
way of inducing SCEs is to deplete BLM from cells (Chaganti
et al., 1974). Low levels of SCEs in SLX4-null cells depleted of
BLM were greatly increased when cells were complemented
with WT SLX4 (Figures 5C and S4). Once again, cells expressing
SLX4DSAP or SLX4DSBDwere not able to complement the SCE
formation suggesting that the SLX4-associated nucleolytic
complex forms an in vivo HJ resolvase with both MUS81 and
SLX1 participating in HJ resolution.
DISCUSSION
Taken together, we show that mitotically growing cells rely on HJ
dissolution provided by BLM-TOP3a-RMI1-RMI2 or HJ resolu-
tion supplied by MUS81-EME1 and SLX1 working together in
the context of SLX4. Because GEN1 is unable to prevent the syn-
thetic lethality of SLX4 and BLM deficiencies, we conclude that
GEN1 cannot substitute for SLX4-dependent activity during HJ
processing in vivo. Our findings in human cells have striking par-
allels to the work from budding yeast, in which the Slx4-Slx1
complex and theMus81-Mms4 complex were identified as being
synthetically lethal with the yeast RecQ helicase Sgs1, a BLM or-
tholog, and also with Top3, SGS1-interacting topoisomerase
(Mullen et al., 2001; reviewed in Rouse, 2009). These parallels
emphasize the evolutionarily conserved redundancy in the pro-
cessing of replication-induced DNA intermediates.
Synthetic lethality between human SLX4 and GEN1 loss
indicates that GEN1 activity is necessary in the setting of SLX4
deficiency even in the presence of BLM complex, showing an
important function of human GEN1 in vivo. This also highlights
that nucleolytic HJ processing is essential for cellular viability
in human cells.
The strict requirement of both MUS81 and SLX1 for the sup-
pression of synthetic lethality in cases of BLM and GEN1 deple-
tion suggests that SLX4-MUS81-EME1-SLX1 forms an in vivo HJ
resolvase as has been previously proposed (Mun˜oz et al., 2009;
Svendsen et al., 2009). We corroborated this finding by showing
that MMC-induced as well as BLM depletion-induced SCEs
were dependent on both MUS81 and SLX1 association with
SLX4. The data presented here suggest a concerted action of
the SLX4-MUS81-EME1-SLX1 complex. It is important, howev-
er, to emphasize that MUS81-EME1 also has functions that are
dependent on SLX4 but that are independent of SLX1. This
notion is supported by previous studies that showed thatmplemented cells depleted of GEN1. Twentymetaphases were scored for each
shown above each graph. Significance was determined by one-way ANOVA. p
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Figure 4. Exogenous Expression of RusA Rescues Chromosomal
Segmentation or Paired Acentric Fragmentation following Depletion
of BLM or GEN1 in SLX4-Null Cells
(A) SLX4-null cells were stably transduced with empty vector, HA-tagged
active RusA, or HA-tagged inactive RusA (D70N). HA-tagged RusA expression
levels are shown by anti-HA western blot analysis.
(B) Quantification of segmented chromosomes in RusA expressing SLX4-null
cells depleted of BLM. Chromosomes with three or more segments were
scored in the indicated cell lines.
(C) Quantification of paired acentric fragments in RusA expressing SLX4-null
cells depleted of GEN1. Acentric fragments in distinct pairs only were scored in
the indicated cell lines.
(B and C) The number of metaphases scored, means, and SDs are shown
above each graph. Analysis was blinded for both experiments in which SLX4-
null cells expressing vector control or active RusA were depleted of control or
BLM protein. Significance was determined by one-way ANOVA. p values are
indicated for the statistically significant comparisons of interest.SLX4DSAP was unable to confer resistance to Topoisomerase I
or to PARP inhibitors and it stresses that SLX4 engages different
nucleases in different lesion contexts (Figure S5). Determining
how SLX4 is regulated will be crucial to the understanding of
the in vivo functions of these nucleases.212 Cell Reports 5, 207–215, October 17, 2013 ª2013 The AuthorsGEN1 depletion in SLX4-null cells led to further suppression of
SCEs, but such suppression was not seen in the SLX4-comple-
mented cells. This suggests that, although GEN1 is capable of
resolving the same structures as SLX4 complexes, SLX4-depen-
dent processes are very efficient at HJ resolution and GEN1may
act as a backup pathway. The observation that GFP-tagged
GEN1 protein expressed from an integrated BAC is cytoplasmic
and may only gain access to the DNA after nuclear envelope
breakdown (Matos et al., 2011) suggests that GEN1 may act in
mitosis on structures that have not been processed by SLX4-
dependent nucleases earlier in the cell cycle. What emerges is
a hierarchy of HJ processing with dissolution using the BLM
complexes being favored because it avoids crossover product
formation with the potential loss of heterozygosity or unequal
sister chromatid exchanges. The second in line during HJ pro-
cessing is the SLX4-dependent resolution and finally GEN1-
dependent resolution is third (Figure 6). Importantly, we show
that there also exist HJ structures that cannot be processed by
BLM complex, and these absolutely require nucleolytic resolu-
tion provided by SLX4 complex or GEN1. It is also possible
that other nucleases capable of action on HJs are still present
in the mitotic cells; however, our synthetic lethality data indicate
that they are unable to substitute for the three activities associ-
ated with BLM, SLX4, and GEN1.
Lack of BLM-dependent dissolution or SLX4-dependent
resolution in mitotically dividing cells results in chromosomal
segmentation that has been previously seen when various
combinations of HJ resolving nucleases were depleted from
BLM-deficient cells (Wechsler et al., 2011). In our experiments,
the absence of both BLM-mediated dissolution and the SLX4-
associated nucleases was sufficient to reveal a robust chromo-
some segmentation phenotype despite the presence of GEN1.
Disappearance of this chromosomal phenotype upon expres-
sion of RusA suggests that segmentation arises due to the
inability to properly process HJs. It is indeed possible that the
sites between segments correspond to the unresolved HJs.
The presence of chromosomal segmentation even when
GEN1 is expressed highlights that GEN1 is unable to process
the apparent high levels of HJs that arise spontaneously when
BLM and SLX4 are absent. Wechsler et al. (2011) observed
robust chromosomal segmentation only after SLX4 (or MUS81)
and GEN1 were depleted. We speculate that the discrepancy
comes from the incomplete siRNA-mediated depletion of
SLX4 (or MUS81) in the previous work thus requiring codeple-
tion of GEN1 in order to observe a robust segmentation
phenotype.
Acentric fragments appearing in the absence of SLX4 and
GEN1 were also efficiently removed when RusA was overex-
pressed, suggesting that they also represent HJs that can be
resolved by RusA. Because the acentric fragments are present
in cells that have robust BLM activity, they have to arise from in-
termediates that cannot be processed by the BLM complex.
Thus, it is possible that these sites may represent unresolved
single HJs. These would not be suitable substrates for dissolu-
tion and would have to be resolved by SLX4 complex or by
GEN1.
Appearance of chromosomal segmentation and acentric frag-
ment formation in cells untreated with anyDNA damaging agents
Figure 5. Both MUS81 and SLX1 Inter-
actions with SLX4 Are Necessary for the
Formation of SLX4-Dependent Sister Chro-
matid Exchanges
(A) Quantification of sister chromatid exchanges
(SCEs) after SLX4-null and complemented cells
were treated with low levels of interstrand cross-
linking agents (1 hr treatment with 0.1 mg of MMC
per milliliter of media).
(B) Quantification of SCEs after siRNA-mediated
depletion of GEN1 from SLX4-null or WT com-
plemented cells and treatment with low levels of
interstrand crosslinking agents.
(C) Quantification of SCEs after siRNA-mediated
depletion of BLM from SLX4-null and com-
plemented cells. SCEs were scored blindly (A) and
(C) and not blindly (B) on 20metaphases from each
cell line. Means and SDs are given above the
graphs. Significance was determined by one-way
ANOVA. p values are indicated for the statistically
significant comparisons.
See also Figure S4.indicates that proper HJ processing is necessary during unper-
turbed replication. Without the HJ processing enzymes, the
unprocessed HJs link the two sister chromatids and hinder the
ability of the mitotic spindle to segregate chromosomes causing
the apparent mitotic demise in cells deficient for SLX4 and BLM
protein or SLX4 and GEN1. The appropriate processing of HR in-
termediates in mitotic mammalian cells is an essential process
for cell viability and the suppression of genomic instability.
Essential processes like these are difficult to dissect as organ-
isms evolve complex backup mechanisms to avert the detri-
mental effects of genome instability such as cell death and
cancer. Our model system has allowed us to address the essen-Cell Reports 5, 207–215,tial aspects of HJ processing, and we
conclude that the SLX4-MUS81-EME1-
SLX1 complex is an in vivo HJ resolvase
in human cells, supplementing BLM-
dependent double HJ dissolvase activity.
Even when the BLM complex is active,
nucleolytic HJ resolution is still essential
for viability and depends on SLX4 and
GEN1 functions.
EXPERIMENTAL PROCEDURES
Cell Lines and Cell Culture
SLX4-null (RA3331/E6E7/hTERT) and comple-
mented cell lines were previously described (Kim
et al., 2013). The SLX4-null patient cell line was
obtained as part of the International Fanconi Ane-
mia Registry study approved by the institutional
review board. Cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented
with 15% (v/v) FBS, 100 units of penicillin per ml,
and 0.1 mg streptomycin per ml (all from Invitro-
gen). Active RusA and inactive RusA (D70N)
expression vectors were a kind gift from the
Monnat lab (University of Washington). The open
reading frames and N-terminal NLS sequenceswere subcloned into lentiviral vectors. Active RusA and inactive rusA stably
expressing cell lines were generated by lentiviral transduction of SLX4-null
(RA3331/E6E7/hTERT) cells.
RNAi
Small interfering RNA (siRNA) (Ambion) were transfected using Lipofectamine
RNAiMAX (Invitrogen) with single siRNAs or pools of three siRNAs as indicated
with a final siRNA concentration of 25 nM. Cells were transfected twice, first by
reverse transfection and 24 hr later by forward transfection as outlined in the
manufacturer’s instructions.
Cell Growth and Survival Assays
Cells transfected twice with siRNAs were collected 72 hr after the first siRNA
transfection and plated in equal number (1,000 cells per well) in a 96-wellOctober 17, 2013 ª2013 The Authors 213
Figure 6. Model of Holliday Junction Pro-
cessing in Mitotically Growing Human Cells
(1) The BLM-TOP3a-RMI1-RMI2 Holliday junction
dissolvase complex facilitates branch migration of
dHJs toward one another and decatenation of the
DNA strands without the use of structure specific
endonucleases. This process yields entirely
noncrossover reaction products. (2) SLX4-asso-
ciated nucleases provide essential nucleolytic
processing of dHJs that are not dissolved in the
absence of the BLM complex. The strict require-
ment of both MUS81 and SLX1 interaction with
SLX4 for the suppression of synthetic lethality in
the absence of BLM as well as the increase of
SCEs after MMC treatment or BLM depletion
suggests that they together form an in vivo HJ
resolvase. (3) GEN1 is able to process HJs but is
unable to prevent the synthetic lethality of SLX4-
BLM deficiency. Both SLX4-dependent and GEN1-mediated resolution of dHJs may yield both crossover and noncrossover products. A single Holliday junction
or another substrate unsuitable for BLM-complex-mediated activity requires SLX4-complexed nucleases or GEN1. GEN1-SLX4 synthetic lethality indicates that
GEN1 activity is necessary in the setting of SLX4 deficiency even in the presence of the BLM complex. In this setting, SLX4-interacting MUS81-EME1 and SLX1
are again required for the suppression of GEN1-SLX4 synthetic lethality.
See also Figure S5.transparent plates for observation and light microscopy or in 96-well Opaque
White Microtest plate (BD Biosciences, 353296). After 5 days in culture, cell
survival was determined using the Cell Titer-Glo reagent (Promega) according
to the manufacturer’s instruction. Survival assay was assessed at least in trip-
licate, and error bars depicted represent SDs.
Metaphase Spreading and Sister Chromatid Exchange Assay
Cells were arrested with colcemid (0.17 mg per ml of media) for 90 min,
harvested, incubated for 10 min at 37C in 0.075 M KCl, and fixed in freshly
prepared methanol:glacial acidic acid (3:1 v/v). Metaphase spreads were
prepared by dropping the cell suspension onto slides prewetted with
ddH20. Slides were dried at 42C for 60 min before staining with KaryoMAX
Giemsa (Invitrogen) in Gurr Buffer for 3 min. After rinsing with fresh Gurr Buffer
followed by distilled water, the slides were fully dried then scanned unmounted
using the Metasystems Metafer application.
Sister chromatid exchange protocol was adapted from Chu et al. (2010).
Cells were cultured for 24 hr in the presence of 10 mg/ml bromodeoxyuridine
(BrdU) (BD Pharmingen). Cells were then treated with 0.1 mg/ml MMC for
1 hr (Sigma Aldrich), washed oncewith PBS, and replenished with fresh culture
media containing a final concentration of 10 mg/ml BrdU and cultured for a
further 24 hr. For sister chromatid exchange analysis of siRNA-depleted cells,
cells were transfected with siRNA twice as described above. Media was sup-
plemented with 10 mg/ml BrdU during the second (forward) transfection. BrdU
labeling, MMC treatment (where appropriate, as indicated in figure legends),
and metaphase preparation were as described above. Slides were differen-
tially stained for sister chromatid exchange analysis as described fully in the
Extended Experimental Procedures.
Live Cell Imaging
For time-lapse microscopy cells were plated on 35 mm glass-bottom dishes
(MatTek) and transferred to an LCV110 VivaView Incubator Microscope
(Olympus) 48 hr following forward transfection of siRNAs. Cells were main-
tained at 37C degrees with 5% CO2 for the duration of imaging (48 hr).
Each stage positionwas imaged every 5min using a 203DIC objective and 0.5
3magnification changer. Images were obtained for DIC and GFP and movies
were prepared using Metamorph software.
Immunofluorescence
Cells were fixed in 3.7% formaldehyde and permeabilized with NP-40, blocked
with PBG (0.2% [w/v] cold fish gelatin, 0.5% [w/v] BSA in PBS), and incubated
with anti-gH2AX (Millipore #05-636) in blocking buffer. Cells were washed and
incubated with the appropriate Alexa Fluor secondary antibody. After three214 Cell Reports 5, 207–215, October 17, 2013 ª2013 The Authorsadditional washes in PBG, the coverslips were embedded in Vectashield
(Vector Laboratories) supplemented with DAPI.
Western Blotting and Immunoprecipitation
For western blotting, cells were lysed directly in Laemmli sample buffer (Bio-
Rad) and separated by 8% or 12% SDS-PAGE prepared using Protogel
(National Diagnostics) as per the manufacturers’ instructions. Proteins were
transferred to PVDF membrane (Immobilon, Millipore) and incubated with pri-
mary antibodies as indicated. For a full list of antibodies, see the Extended
Experimental Procedures. For immunoprecipitations, cells were lysed in
MCLB (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 0.5% Nonidet P-40) sup-
plemented with protease inhibitors (Roche Diagnostics). A total of 1 mg of pro-
tein extract was incubated with 10 ml of anti-HA agarose (Sigma-Aldrich, A
2095). Immunoprecipitates were eluted in Tris-glycine SDS sample buffer
and size fractionated on Novex 3%–8% Tris-Acetate gel (Invitrogen).
Quantitative RT-PCR
Total RNA was prepared using RNeasy kit (QIAGEN) as suggested by the
manufacturer. Total RNA (1 mg) was reverse transcribed with SuperScript III
First-Strand Synthesis Supermix (Invitrogen) and used for quantitative RT-
PCR using Platinum SYBRGreen qPCR SuperMix-UDG (Invitrogen) according
to the manufacturer’s instruction. Primers are listed in Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and one table and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2013.08.041.
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